Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 47 of the 48 references it cites were found in a registry or an index.

Suppression of Hypoxia-Inducible Factor 1α (HIF-1α) by Tirapazamine Is Dependent on eIF2α Phosphorylation Rather Than the mTORC1/4E-BP1 Pathway

Open access

Abstract

Hypoxia-inducible factor 1 (HIF-1), a heterodimeric transcription factor that mediates the adaptation of tumor cells and tissues to the hypoxic microenvironment, has attracted considerable interest as a potential therapeutic target. Tirapazamine (TPZ), a well-characterized bioreductive anticancer agent, is currently in Phase II and III clinical trials. A major aspect of the anticancer activity of TPZ is its identity as a tumor-specific topoisomerase IIα inhibitor. In the study, for the first time, we found that TPZ acts in a novel manner to inhibit HIF-1α accumulation driven by hypoxia or growth factors in human cancer cells and in HepG2 cell-derived tumors in athymic nude mice. We investigated the mechanism of TPZ on HIF-1α in HeLa human cervical cancer cells by western blot analysis, reverse transcription-PCR assay, luciferase reporter assay and small interfering RNA (siRNA) assay. Mechanistic studies demonstrated that neither HIF-1α mRNA levels nor HIF-1α protein degradation are affected by TPZ. However, TPZ was found to be involved in HIF-1α translational regulation. Further studies revealed that the inhibitory effect of TPZ on HIF-1α protein synthesis is dependent on the phosphorylation of translation initiation factor 2α (eIF2α) rather than the mTOR complex 1/eukaryotic initiation factor 4E-binding protein-1 (mTORC1/4E-BP1) pathway. Immunofluorescence analysis of tumor sections provide the in vivo evidences to support our hypothesis. Additionally, siRNA specifically targeting topoisomerase IIα did not reverse the ability of TPZ to inhibit HIF-1α expression, suggesting that the HIF-1α inhibitory activity of TPZ is independent of its topoisomerase IIα inhibition. In conclusion, our findings suggest that TPZ is a potent regulator of HIF-1α and provide new insight into the potential molecular mechanism whereby TPZ serves to reduce HIF-1α expression.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0013910

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 TPZ decreases hypoxia-induced HIF-1α protein accumulation. HeLa cells (A), and HEK-293, OVCAR8, HepG2, SMMC-7721 and HCT116 cells (B) were exposed to hypoxia and a gradient of concentrations of TPZ for 4 h. HIF-1α and β-actin protein levels were detected by western-blot analysis of whole-cell extracts, as described in the Materials and Methods. (C) Effect of TPZ treatment on the expression level of HIF-1α in HepG2 cell-derived tumors, as determined by immunoblot analysis. (D) Densitometry analyses of (C). (E) Hypoxia-dependent HIF-1α transcriptional activity was measured using HRE-dependent reporter assays, as described in the Materials and Methods. HeLa cells were transiently transfected with the HRE-Luc plasmid and then treated with TPZ for 8 h under hypoxic conditions. Luminescence was measured and fold stimulation was obtained by normalizing the relative luciferase activity to that of untreated cells under hypoxic conditions.
Figure 1 TPZ decreases hypoxia-induced HIF-1α protein accumulation. HeLa cells (A), and HEK-293, OVCAR8, HepG2, SMMC-7721 and HCT116 cells (B) were exposed to hypoxia and a gradient of concentrations of TPZ for 4 h. HIF-1α and β-actin protein levels were detected by western-blot analysis of whole-cell extracts, as described in the Materials and Methods. (C) Effect of TPZ treatment on the expression level of HIF-1α in HepG2 cell-derived tumors, as determined by immunoblot analysis. (D) Densitometry analyses of (C). (E) Hypoxia-dependent HIF-1α transcriptional activity was measured using HRE-dependent reporter assays, as described in the Materials and Methods. HeLa cells were transiently transfected with the HRE-Luc plasmid and then treated with TPZ for 8 h under hypoxic conditions. Luminescence was measured and fold stimulation was obtained by normalizing the relative luciferase activity to that of untreated cells under hypoxic conditions.CC BY · PubMed Central
Figure 2 TPZ does not affect HIF-1α mRNA expression or protein degradation, but decreases HIF-1α protein synthesis. (A) HeLa cells were exposed to varying concentrations of TPZ for 4 h or a single concentration for the indicated times. Then, the total RNA was extracted and analyzed for HIF-1α mRNA expression by RT-PCR, using GAPDH as a control gene. (B) Cells exposed to hypoxia overnight were treated with cycloheximide (CHX) in the presence or absence of 20 µM TPZ for various periods, and HIF-1α protein levels were measured by western-blot analysis. HeLa cells were treated with TPZ, together with MG132 (C) or chloroquine diphosphate (CQ) (D), under the indicated conditions, followed by immunoblotting with anti-HIF-1α or anti-β-actin antibodies. Cells were pretreated for 30 min with MG132 and CQ to allow functional inhibition of the proteasome and lysosome. (E) HeLa cells were pre-incubated with CHX for 3 h in normoxic conditions and then placed in fresh medium and treated with or without 20 µM TPZ for the indicated times under hypoxic conditions. The cells were harvested and lysates were immunoblotted with an anti-HIF-1α antibody.
Figure 2 TPZ does not affect HIF-1α mRNA expression or protein degradation, but decreases HIF-1α protein synthesis. (A) HeLa cells were exposed to varying concentrations of TPZ for 4 h or a single concentration for the indicated times. Then, the total RNA was extracted and analyzed for HIF-1α mRNA expression by RT-PCR, using GAPDH as a control gene. (B) Cells exposed to hypoxia overnight were treated with cycloheximide (CHX) in the presence or absence of 20 µM TPZ for various periods, and HIF-1α protein levels were measured by western-blot analysis. HeLa cells were treated with TPZ, together with MG132 (C) or chloroquine diphosphate (CQ) (D), under the indicated conditions, followed by immunoblotting with anti-HIF-1α or anti-β-actin antibodies. Cells were pretreated for 30 min with MG132 and CQ to allow functional inhibition of the proteasome and lysosome. (E) HeLa cells were pre-incubated with CHX for 3 h in normoxic conditions and then placed in fresh medium and treated with or without 20 µM TPZ for the indicated times under hypoxic conditions. The cells were harvested and lysates were immunoblotted with an anti-HIF-1α antibody.CC BY · PubMed Central
Figure 3 Effects of TPZ on Akt and the mTORC1 pathway in HeLa cells. (A) Cells were cultured in hypoxia for 4 h in the presence of the indicated concentrations of TPZ before western-blotting analysis. (B) Immunoprecipitates prepared from the lysates of HeLa cells with Raptor antibody were used in kinase assays with full-length 4EBP1 as the substrate. (C) Immunoblotting was used to detect the phosphorylation of Akt at Ser473 or Thr308 after TPZ treatment. HeLa cells were transfected with siRNAs specifically targeting TSC2 (D) and 4E-BP1 (E) or control siRNAs, as described in the Materials and Methods. Transfected cells were incubated with or without 20 µM TPZ for 4 h under hypoxic conditions. Proteins were detected by western-blot analysis using specific antibodies.
Figure 3 Effects of TPZ on Akt and the mTORC1 pathway in HeLa cells. (A) Cells were cultured in hypoxia for 4 h in the presence of the indicated concentrations of TPZ before western-blotting analysis. (B) Immunoprecipitates prepared from the lysates of HeLa cells with Raptor antibody were used in kinase assays with full-length 4EBP1 as the substrate. (C) Immunoblotting was used to detect the phosphorylation of Akt at Ser473 or Thr308 after TPZ treatment. HeLa cells were transfected with siRNAs specifically targeting TSC2 (D) and 4E-BP1 (E) or control siRNAs, as described in the Materials and Methods. Transfected cells were incubated with or without 20 µM TPZ for 4 h under hypoxic conditions. Proteins were detected by western-blot analysis using specific antibodies.CC BY · PubMed Central
Figure 4 A direct role of eIF2α phosphorylation in HIF-1α downregulation by TPZ. (A) HeLa cells treated with indicated concentrations of TPZ for 4 h under hypoxic conditions. Total lysates were probed for expression of HIF-1α, p-eIF2α, and eIF2α, while β-actin served as a loading control. (B) HeLa cells were exposed to varying concentrations of TPZ for 4 h. GADD153 mRNA levels were determined by real-time PCR. The relative fold change of GADD153 mRNA compared to GAPDH mRNA in untreated cells under hypoxia was arbitrarily set as 1.0. (C) The effect of TPZ treatment to basal protein synthesis was measured using ODD-dependent reporter assays. HeLa cells were transiently transfected with the ODD-Luc plasmid and then treated with TPZ for 4 h under normoxia or hypoxia. Luminescence was measured and fold stimulation was obtained by normalizing the relative luciferase activity of cells cultured under hypoxic conditions to those of untreated cells cultured under normoxic conditions. (D) Cells were untransfected or transfected with eIF2α-targeting siRNA for two days, followed by treatment with or without 20 µM TPZ. Western blotting of cell lysates was performed using the indicated antibodies.
Figure 4 A direct role of eIF2α phosphorylation in HIF-1α downregulation by TPZ. (A) HeLa cells treated with indicated concentrations of TPZ for 4 h under hypoxic conditions. Total lysates were probed for expression of HIF-1α, p-eIF2α, and eIF2α, while β-actin served as a loading control. (B) HeLa cells were exposed to varying concentrations of TPZ for 4 h. GADD153 mRNA levels were determined by real-time PCR. The relative fold change of GADD153 mRNA compared to GAPDH mRNA in untreated cells under hypoxia was arbitrarily set as 1.0. (C) The effect of TPZ treatment to basal protein synthesis was measured using ODD-dependent reporter assays. HeLa cells were transiently transfected with the ODD-Luc plasmid and then treated with TPZ for 4 h under normoxia or hypoxia. Luminescence was measured and fold stimulation was obtained by normalizing the relative luciferase activity of cells cultured under hypoxic conditions to those of untreated cells cultured under normoxic conditions. (D) Cells were untransfected or transfected with eIF2α-targeting siRNA for two days, followed by treatment with or without 20 µM TPZ. Western blotting of cell lysates was performed using the indicated antibodies.CC BY · PubMed Central
Figure 5 TPZ reduces HIF-1α protein only under hypoxic conditions, and its activity is independent of its topoisomerase II inhibition. (A) HeLa cells were exposed to normoxic conditions for 4 h in the presence of TPZ. (B) Cells were treated with varying concentrations of TPZ for 4 h, as indicated, in the presence of the hypoxia-mimetic agent cobalt chloride (CoCl2). (C) HeLa cells were treated for 4 h in normoxia, hypoxia or with CoCl2 in the presence of TPZ at the indicated concentrations. (D) Cells were treated with 20 µM TPZ, 20 µM etoposide and 10 µM adriamycin for 4 h. (E) Topoisomerase IIα was knocked down using siRNA, as described in the Materials and Methods, followed by drug treatment (20 µM TPZ, 20 µM etoposide and 10 µM adriamycin). Proteins were detected by western-blot analysis.
Figure 5 TPZ reduces HIF-1α protein only under hypoxic conditions, and its activity is independent of its topoisomerase II inhibition. (A) HeLa cells were exposed to normoxic conditions for 4 h in the presence of TPZ. (B) Cells were treated with varying concentrations of TPZ for 4 h, as indicated, in the presence of the hypoxia-mimetic agent cobalt chloride (CoCl2). (C) HeLa cells were treated for 4 h in normoxia, hypoxia or with CoCl2 in the presence of TPZ at the indicated concentrations. (D) Cells were treated with 20 µM TPZ, 20 µM etoposide and 10 µM adriamycin for 4 h. (E) Topoisomerase IIα was knocked down using siRNA, as described in the Materials and Methods, followed by drug treatment (20 µM TPZ, 20 µM etoposide and 10 µM adriamycin). Proteins were detected by western-blot analysis.CC BY · PubMed Central
Figure 6 The effect of TPZ on HepG2 human xenograft models. The mice transplanted with HepG2 human xenograft were randomly divided into two groups and given injection of TPZ (30 mg/kg) or vehicle every 2 days. Representative photomicrographs (magnification, x100) showing immunofluorescence staining for HIF-1α (A) and p-eIF2α (B) in tumor sections of vehicle–treated and TPZ-treated mice. The immunostaining data were confirmed in two or more specimens of each group. (C) Tumor volume are expressed as mean ± SD. (D) Relative tumor volume are expressed as mean ± SD. (**p<0.01, relative to vehicle group).
Figure 6 The effect of TPZ on HepG2 human xenograft models. The mice transplanted with HepG2 human xenograft were randomly divided into two groups and given injection of TPZ (30 mg/kg) or vehicle every 2 days. Representative photomicrographs (magnification, x100) showing immunofluorescence staining for HIF-1α (A) and p-eIF2α (B) in tumor sections of vehicle–treated and TPZ-treated mice. The immunostaining data were confirmed in two or more specimens of each group. (C) Tumor volume are expressed as mean ± SD. (D) Relative tumor volume are expressed as mean ± SD. (**p<0.01, relative to vehicle group).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 48 references

Research works printed but not linked: 1

  1. YM Delahoussaye, 2001, Metabolism of tirapazamine by multiple reductases in the nucleus., Biochem Pharmacol, 62, 1201

Cited by

See all 57

Metadata

Authors
Zhang, J., Cao, J., Weng, Q., Wu, R., Yan, Y., Jing, H., Zhu, H., He, Q., & Yang, B.
Affiliations
Zhejiang University (CN)
Corresponding author
  • He, Qiaojun
  • Yang, Bo
Venue
PLoS ONE
Published
2010-11-09
Volume
5
Issue
11
Pages
e13910
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2062776433
Cited by
56
References
48
Citations by year
2026: 1 · 2025: 2 · 2024: 1 · 2023: 1 · 2022: 7 · 2021: 1 · 2020: 1 · 2019: 1 · 2018: 6 · 2017: 5 · 2016: 5 · 2015: 4 · 2014: 7 · 2013: 7 · 2012: 3
FWCI
1.41
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Figshare (submittedVersion, cc-by)
Funders
  • Chinese Academy of Sciences
  • Fundamental Research Funds for the Central Universities
  • Natural Science Foundation of Zhejiang Province (Z2090053)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
Keywords
tirapazamine, hypoxia-inducible factor-1α, eIF2α phosphorylation, translational regulation, TOP2A, tumor hypoxia, HeLa cervical cancer cells
MeSH terms
Mechanistic Target of Rapamycin Complex 1, Tirapazamine, Animals, Antigens, Neoplasm, Antineoplastic Agents, DNA Topoisomerases, Type II, DNA-Binding Proteins, Female, HeLa Cells, Humans, Liver Neoplasms, Experimental, Mice, Inbred BALB C, Mice, Nude, Phosphoproteins, Phosphorylation, Proteins, Transplantation, Heterologous, Triazines, Blotting, Western, Signal Transduction, Cell Hypoxia, Eukaryotic Initiation Factor-2, Cell Cycle Proteins, Reverse Transcriptase Polymerase Chain Reaction, RNA Interference, Cell Line, Tumor, Multiprotein Complexes, Adaptor Proteins, Signal Transducing, Mice, Hypoxia-Inducible Factor 1, alpha Subunit, Hep G2 Cells, HEK293 Cells, TOR Serine-Threonine Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Suppression of Hypoxia-Inducible Factor 1α (HIF-1α) by Tirapazamine Is Dependent on eIF2α Phosphorylation Rather Than the mTORC1/4E-BP1 Pathway. https://app.cochat.ai/papers/10.1371/journal.pone.0013910
The paper
Zhang, J., Cao, J., Weng, Q., Wu, R., Yan, Y., Jing, H., Zhu, H., He, Q., & Yang, B. (2010). Suppression of Hypoxia-Inducible Factor 1α (HIF-1α) by Tirapazamine Is Dependent on eIF2α Phosphorylation Rather Than the mTORC1/4E-BP1 Pathway. PLoS ONE. https://doi.org/10.1371/journal.pone.0013910

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.